Cal-Maine Foods heads into its July 21 Q1 earnings print with a split personality: short sellers are quietly rebuilding positions into a 6% weekly rally, while options traders have done the opposite — rotating decisively toward calls at the most aggressive pace in months.
The clearest signal this week is in options, and it runs counter to recent history. The put/call ratio has dropped to 0.82, nearly 1.6 standard deviations below its 20-day average of 1.12. That's a sharp reversal from the defensive posture that dominated through May and early June, when the PCR ran consistently above 1.30. Call buyers have taken over as the stock climbed 13% over the past month to $85.41, suggesting the rally has pulled in fresh bullish positioning rather than merely covering prior hedges.
Short positioning tells the contrasting story. At 11.3% of the free float, short interest is meaningfully elevated — and it has been quietly climbing this week, up roughly 2.3% on the week after a month-on-month dip of 3.5%. The borrow market offers no added pressure for shorts to cover: availability is running at a comfortable 211%, meaning roughly two shares are available to borrow for every one already shorted. Cost to borrow has also eased, falling 17% on the week to just 0.47% — generationally cheap. That combination of rising short interest and loose borrow conditions suggests fresh short sellers are entering with ease, not scrambling to exit. The ORTEX short score has drifted higher to 68.1, its best reading in at least two weeks, consistent with gradual short-side accumulation rather than a capitulation event.
The Street sits squarely on the fence. The two active coverage firms — BMO Capital and Stephens & Co. — both hold neutral ratings, with targets that have migrated downward from the $95–$105 range of late 2025. The most recent action, a BMO target trim to $80 in late March, placed the stock below where it trades today at $85.41; Stephens moved the other direction in mid-March, nudging its target up to $90. The consensus mean sits at $86.75, barely above the current price, which tells its own story about how little upside the Street is pricing in. On valuation, the stock trades at roughly 12x trailing earnings and 1.25x book — undemanding multiples that reflect the bull case: egg prices elevated, prepared-foods capacity expanding, and a production pipeline that looks healthy on chick hatch and incubator metrics. The bear case centres on the structural reset underway — net sales down nearly 20% from peak, conventional flock volume declining 13.6% year-on-year, and EPS estimates still drifting lower. Factor scores amplify the tension: EPS surprise ranks in the 82nd percentile, consistent with a company that has repeatedly beaten low expectations, but forward EPS momentum sits in the 17th percentile, reflecting analyst downgrades that haven't stopped.
Institutional flows add one genuine piece of colour. BlackRock added 408,000 shares in the quarter to June 30, lifting its stake to 6.95 million shares — 14.7% of the company. Dimensional Fund Advisors and First Trust also added meaningfully in the same period. The passive-heavy nature of those additions mutes the signal somewhat, but the absence of notable selling among top holders into a multi-month high is worth noting alongside the bearish analyst tone.
Recent earnings history is consistent, if modest: the stock fell around 1–2% the day after each of the last two prints, with five-day moves of roughly -2.5% to -4.5% following. The question for July 21 is whether the options rotation toward calls reflects genuine conviction that egg prices hold, or whether it's simply the momentum trade chasing a stock that has moved 13% in a month into a print where the Street sees almost no further upside from here.
See the live data behind this article on ORTEX.
Open CALM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
